why choose us

First received: December 27, 2022

Clinical Trial: Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece

Study Status: Completed

Recruit Status: Completed

Condition: Diabetic Macular Edema

Study Type: Observational


Official Title: Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece: The ADMIRE Study

Brief Summary: ADMIRE was a prospective, observational cohort study of patients with diabetic macular edema (DME). Efficacy was assessed by change in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) from baseline to months 12, 24 and 36 after treatment with intravitreal aflibercept in treatment-naïve patients and previously treated patients. Safety was evaluated by recording any patients-reported events.

Read more